CrissmanJ DZarboR JDysplasia, in situ carcinoma and progression to invasive squamous cell carcinoma in the upper acrodigestive tract. American Journal of Surgical Pathology1989;13: 5–16.
2.
MincerH HSidneyM SColemanS AHopkinsK PObservations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surgery1972;33: 389–399.
3.
KaugarsG EBurnsJ CGunsolleyJ CEpithelial dysplasia of the oral cavity and lips. Cancer1988;62: 2166–2170.
4.
BanoczyJSugarL. Progressive and regressive changes in Hungarian oral leukoplakias in the course of longitudinal studies. Community Dentistry and Oral Epidemiology1975;3: 194–197.
5.
SankaranarayananRDuffyS WDayN EA case control investigation of cancer of the oral tongue and the floor of the mouth in Southern India. International Journal of Cancer1989;44: 617–621.
6.
BanoczyJCsibaA. Occurrence of epithelial dysplasia in oral leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology1976;42: 766–774.
7.
BanoczyJ. Follow-up studies in oral leukoplakia. Journal of Maxillofacial Surgery1977;5: 69–75.
8.
PindborgJ JJoistORenstrupGRoed-PetersenB. Studies in oral leukoplakia. A preliminary report on the period prevalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. Journal of the American Dental Association1968;76: 767–771.
9.
PindborgJ JDaftaryD KMehtaF SA follow-up study of 61 oral dysplastic precancerous lesions in Indian villagers. Oral Surgery1977;43: 383–390.
10.
EinhornJWersallJ. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer1967;20: 2189–2193.
11.
BhargavaKSmithL WManiNJSilvermanSMalaowallaA MBilimoriaK FA follow-up study of oral cancer and precancerous lesions in 57,518 industrial workers of Gujarat, India. Indian Journal of Cancer1975;12: 124–129.
12.
SilvermanSJrGorskyMLozadaF. Oral leukoplakia and malignant transformation: A follow-up study of 257 patients. Cancer1984;53: 563–568.
13.
SilvermanSJrBhargavaKManiN JMalignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat India. Cancer1976;38: 1790–1795.
14.
GuptaP CMehtaF SDaftaryD KIncidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Comm Dent Oral Epidemiol1980;8: 325–326.
15.
GuptaP CBhonsleR BMurtiP RDaftaryD KMehtaF SPindborgJ JAn epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer1989;63: 2247–2252.
16.
HongW KEndicottJItriL M13-cis retinoic acid in the treatment of oral leukoplakia. New England Journal of Medicine1986;315: 1501–1505.
17.
KramerI RLucasR BPindborgJ JSobinL HDefinition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surgery, Oral Medicine, Oral Pathology1978;46: 518–539.
18.
ShklarG. Oral leukoplakia. New England Journal of Medicine1986;315: 1544–1546.
19.
WaldronC AShaferW GLeukoplakia revisted: A clinicopathologic study of 3256 oral leukoplakias. Cancer1975;36: 1386–1392.
20.
GangadharanPPaymasterJ CLeukoplakia — An epidemiologic study of 1504 cases observed at the Tata Memorial Hospital, Bombay, India. British Journal of Cancer1971;25: 657–668.
21.
ScullyCBurkhardtA. Tissue markers of potentially malignant oral epithelial lesions. Journal of Oral Pathology and Medicine1993;22: 246–256.
22.
SugarLBanoczyJ. Follow-up studies in oral leukoplakia. Bulletin of the World Health Organization1969;41: 289–293.
23.
SilvermanSJrRozenR D. Observation of the clinical characteristics and natural history of oral leukoplakia. Journal of the American Dental Association1968;76: 772–776.
24.
BaricJ MAlmanJ EFeldmanR SChaunceyH HInfluence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surgery1982;54: 424–429.
25.
MehtaF SPindborgJ JDaftaryD KGuptaP COral leukoplakia among Indian villagers. The association with smoking habits. British Dental Journal1969;127: 73–77.
26.
MehtaF SShroffB CGuptaP CDaftaryD KOral leukoplakia in relation to tobacco habits: A ten-year follow up of Bombay policemen. Oral Surgery1972;34: 426–433.
27.
MehtaF SGuptaV CDaftaryD KPindborgJ JChoksiS. An epidemiologic study of oral cancer and precancerous conditions among villagers in Maharashtra, India. International Journal of Cancer1972;10: 134–137.
28.
Roed-PetersenBGuptaP CPindborgJ JSinghB. Association between oral leukoplakia and sex, age and tobacco habits. Bulletin of the World Health Organization1972;47: 13–19.
29.
AxellTHolmstrupPKramerI R HPindborgJ JShearM. International seminar on oral leukoplakia and associated lesions related to smoking habits. Community Dentistry and Oral Epidemiology1984;12: 145–154.
30.
AxellTMorstadHSunderstromB. The relation of the clinical picture to the histopathology of snuff dipper's lesions in a Swedish population. Journal of Oral Pathology1976;5: 229–236.
31.
ArendorfT MWalkerD MKingdomRJRollJ R SNewcombeR GTobacco smoking and denture wearing in oral and candidal leukoplakia. British Dental Journal1983;155: 340–343.
32.
FieldE AFieldJ KMartinM VDoes Candida have a role in oral epithelial neoplasia. Journal of Medical and Veterinary Mycology1989;27: 277–294.
33.
KroghPHaldBHolmstrupP. Possible mycological etiology of oral mucosal cancer: Catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis1987;8: 1543–1548.
34.
KroghP. The role of yeasts in oral cancer by means of endogenous nitrosation. Acta Odontologica Scandinavica1990;48: 85–88.
35.
Roed-PetersenBRenstrupGPindborgJ JCandida in oral leukoplakia. Scandinavian Journal of Dental Research1970;78: 323–328.
36.
MoertelC GFossE LMulticentric carcinomas of the oral cavity. Surgical, Gynecology and Obstetrics1958;106: 652–654.
37.
ShibuyaHAmagasaTSetoK-ILeukoplakia-associated multiple carcinomas in patients with tongue carcinoma. Cancer1986;57: 843–846.
38.
ShaferW GWaldronC AA clinical and histopathological study of oral leukoplakia. Surgical, Gynecology and Obstetrics1961;112: 411–420.
39.
MashbergAMorriseyJ BGarfinkelL. A study of the appearance of early asymptomatic oral squamous cell carcinoma. Cancer1973;32: 1436–1445.
40.
MashbergA. Erythroplasia vs leukoplakia in the diagnosis of early asymptomatic oral squamous carcinoma. New England Journal of Medicine1977;297: 109–110.
41.
ChiesaFBoracchiPTradatiNRisk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncology European Journal of Cancer Part B1993;29B: 23–28.
42.
PindborgJ JRoed-PetersenBRenstrupG. Role of smoking in floor of the mouth leukoplakias. Journal of Oral Pathology1972;1: 22–29.
43.
SalonenLAxellTHelldenL. Occurrence of oral mucosa lesions: The influence of tobacco habits and an estimate of treatment time in an adult Swedish population. Journal of Oral Pathology and Medicine1990;19: 170–176.
44.
ChristenA GThe impact of tobacco use and cessation on oral and dental diseases and conditions. American Journal of Medicine1992;93: (1A)25S–(1A) 31S.
International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risk to humans. Tobacco smoking. 38. Lyon: IARC, 1986.
47.
International Agency for Research on Cancer. Monographs on the evaulation of the carcinogenic risk to humans. Alcohol drinking. 44. Lyon: IARC, 1988.
48.
International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risk to humans. Tobacco habits other than smoking. 37. Lyon: IARC, 1985.
49.
FreedmanAShklarG. Alcohol and hamster buccal pouch carcinogenesis. Oral Surgery1978;46: 794–805.
50.
BlotW JWinnD MFraumeniJ FOral cancer and mouthwash. Journal of the National Cancer Institute1983;70: 251–253.
51.
RothmanK JKellerA ZThe effect of joint exposure to alcohol and tobacco on the risk of cancer of the mouth and pharynx. Journal of Chronic Disease1972;25: 711–716.
52.
GrahamSDayalHRohrerTDentition, diet, tobacco and alcohol in the epidemiology of oral cancer. Journal of the National Cancer Institute1977;59: 1611–1618.
53.
BlotW JMcLaughlinJ KWynnD MSmoking and drinking in relation to oral and pharyngeal cancer. Cancer Research1988;48: 3282–3287.
54.
MerlettiFBoffetaPCiconeGRole of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy. Cancer Research1989;49: 4919–4924.
55.
FrancoE LKowalskiL POliveiraB VRisk factors for oral cancer in Brazil: A case control study. International Journal of Cancer1989;43: 992–1000.
56.
StichH FTsangS SPromoting activity of betel quid ingredients and their inhibition by retinol. Cancer Letters1989;45: 71–77.
57.
GrahamSMettlinCMarshallJDietary factors in the epidemiology of cancer of the larynx. American Journal of Epidemiology1981;113: 575–680.
58.
WinnD MZieglerR GPickleL WDiet in the etiology of oral and pharyngeal cancer among women from the Southern US. Cancer Research1984;44: 1216–1222.
59.
NotaniPJayantK. Role of diet in upper aerodigestive tract cancers. Nutrition and Cancer1987;10: 103–113.
60.
ZieglerR GA review of epidemiologic evidence that carotenoids reduce the risk of cancer. Journal of Nutrition1989;119: 116–122.
61.
BoylePMacFarlaneG JZhengTRecent advances in epidemiology of head and neck cancer. Current Opinion in Oncology1992;4: 471–477.
62.
MarshallJGrahamSMettlinCSheddDSwansonM. Diet in the epidemiology of oral cancer. Nutrition and Cancer1982;3: 145–149.
63.
ZhengWBlotW JDiamondE LSerum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Research1993;53: 795–798.
64.
McLaughlinJ KGridleyGBlockGDietary factors in oral and pharyngeal cancer. Journal of the National Cancer Institute1988;80: 1237–1243.
65.
GridleyGMcLaughlinJ KBlockGDiet and oral and pharyngeal cancer among blacks. Nutrition and Cancer1990;14: 219–225.
66.
Council on Scientific Affairs. Diet and cancer; where do matters stand?Archives of Internal Medicine1993;153: 50–56.
67.
PetoRDollRBuckleyJ DSpornM BCan dietary beta-carotene materially reduce human cancer rates?Nature1981;290: 201.
68.
IbrahimKJafareyN AZuberiS JPlasma vitamin ‘A’ and carotene levels in squamous cell carcinoma of the oral cavity and oropharynx. Clinical Oncology1977;3: 203–207.
69.
FexGWahlbergPBiorklundAStudies of cellular retinol-binding protein (CRBP) in squamous cell carcinomas of the head and neck region. International Journal of Cancer1986;37: 217–221.
70.
RamaswamyP GKrishnamorthyLRaoV RBhargavaM KVitamin and provitamin A levels in epithelial cancers. Nutrition and Cancer1990;14: 273–276.
71.
De VriesNSnowG BRelationship of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumours. European Archives of Orlo-Rhino-Laryngology1990;247: 368.
72.
BichlerEDaxenbichlerGMarthC. Vitamin A status and retinoid-binding proteins in carcinomas of the head and neck region. Oncology1983;40: 336–339.
73.
BichlerEDaxenbichlerG. Retinoic acid-binding protein in human squamous cell carcinomas of the ORL region. Cancer1982;49: 619–622.
74.
HuLCroweD LRheinwaldJ GChambonPGudasL JAbnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Research1991;51: 3972–3981.
75.
DoreyJ LBlasbergBConklinR JCarmichaelR POral leukoplakia. Current concepts in diagnosis, management and malignant potential. International Journal of Dermatology1984;23: 638–642.
76.
LameyP-J.Management options in potentially malignant and malignant oral epithelial lesions. Community Dental Health1992;10 (suppl 1): 53–62.
77.
ScullyC. Clinical diagnostic methods for the detection of premalignant and early malignant oral lesions. Community Dental Health1993;10 (suppl 1): 43–52.
78.
HendersonB ERossR KPikeM CToward the primary prevention of cancer. Science1991;254: 1131–1137.
79.
ChiesaFTradatiNSalaL. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Archives Otolaryngology Head and Neck Surgery1990;116: 177–180.
80.
PindborgJ JPathology of oral leukoplakia. American Journal of Dermatopathology1980;2: 277.
81.
Roed-PetersenB. Effect on oral leukoplakia of replacing or ceasing tobacco smoking. Acta Dermato-Venereologica1982;62: 164–167.
82.
GiuntaJ LConnollyG. The reversibility of leukoplakia caused by smokeless tobacco. JADA1986;113: 50–52.
83.
MehtaF SGuptaM BPindborgJ JBhonsleR BJalnawallaP NSinorP NAn intervention study of oral cancer and precancer in rural Indian populations: A preliminary report. Bulletin of the World Health Organization1982;60: 441–446.
84.
GuptaP CMehtaF SPindborgJ JPrimary prevention of oral cancer among Indian villagers. Eight-year follow-up results. IARC Scientific Publications1990;103: 149–156.
85.
InczeJVaughanC WJrLuiPPremalignant changes in normal appearing epithelium in patients with squamous cell carcinoma of the upper aerodigestive tract. American Journal of Surgery1982;144: 401–405.
86.
KochH FEffect of retinoids on precancerous lesions of oral mucosa. In: Retinoids: advances in basic research and therapy. OrfanosCEBraun-FalcoOFarberE M, eds. Berlin: Springer, 1981;307–312.
87.
HongW KDoosW GChemoprevention of head and neck cancer: Potential use of retinoids. Otolaryngology Clinics North America1985;18: 543–549.
88.
ScullyCBoyleP. Vitamin A and related compounds in chemoprevention of potentially malignant oral lesions and carcinoma. Oral Oncology European Journal of Cancer Part B1992;28B: 87–89.
89.
RichtsmeierW JBiologic modifiers and chemoprevention of cancer of the oral cavity. New England Journal of Medicine1993;328: 58–59.
90.
Van PoppelG. Carotenoids and cancer: An update with emphasis on human intervention studies. European Journal of Cancer1992;29A: 1335–1344.
91.
SilvermanSRenstrupGPindborgJ JStudies in oral leukoplakia. III. Effects of vitamin A comparing clinical, histopathologic, cytologic and hematologic responses. Acta Odontologica Scandinavica1963;21: 271.
92.
SilvermanSRenstrupGPindborgJ JStudies in oral leukoplakia. VII. Further investigations on the effects of vitamin A on keratinization. Acta Odontologica Scandinavica1963;21: 553.
93.
SilvermanSEisenbergERenstrupG. A study of the effects of high doses of vitamin A on oral leukoplakia (hyperkeratosis) including toxicity, liver function and skeletal metabolism. Journal of Oral Therapeutic Pharmacology1965;2: 9–23.
94.
StichH GDunnB PRelationship between cellular levels of beta-carotene and sensitivity to genotoxic agents. International Journal of Cancer1987;38: 713–717.
95.
SmithJ FClinical evaluation of massive buccal vitamin A dosage in oral hyperkeratosis. Oral Surgery1962;15: 282–292.
96.
KovacsG YPreblastomatosis of oral cavity. Thesis, Budapest, 1962.
97.
KovacsG YDie moderne diagnostik und therapie von prablastomatosen der mundhole. Ther Hung1962;10: 1–3.
98.
SpiesslBMetzH JDifferential diagnosis and treatment of leukoplakia (German). Zahn Punol Kieferheilk1967;48, 1: 11–20.
99.
MulayD NUrbachF. Local therapy of oral leukoplakia with vitamin A. Archives of Dermatology1958;78: 637.
100.
SchreyMEsserE. Exfoliativ Zytologie im Verlauf der Lokalbehandlung der intraoralen Leukoplakie mit Vitamin-A-saure. Dtsch Zahnartzl Z1978;3: 143–145.
101.
KochHSchettlerD. Klinische Erfahrungen mit Vitamin A-Saure Derivaten bei der Behandlung von Leukoplakien der Mundschleimhaut. Dtsch Zahnartzl Z1973;28: 623–627.
102.
EhrlP AKlinische Untersuchung eines aromatischen retinoids (Ro-10–9359) zur Behandlung oraler Hyperkeratosen. Dtsch Zahnartzl Z1980;35: 554–558.
103.
KochH FBiochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid. Journal of Maxillofacial Surgery1978;6: 59–63.
104.
CorderoA AAllevatoM A JBarclayC ATreatment of lichen planus and leukoplakia with the oral retinoid Ro-10–0359. In: OrfanosC E, eds. Retinoids. Basel: Springer, 1981;273–278.
105.
MeyskensF LJrGoodmanG EAlbertsD S13-cis-retinoic acid: Pharmacology, toxicology and clinical applications for the prevention and treatment of human cancer. CRC Critical Reviews in Oncology and Hematology1985;3: 75–101.
106.
LippmanS MKesslerJ FMeyskensF LRetinoids as preventive and therapeutic anticancer agents. Part 1. Cancer Treatment Report1987;71: 391–405.
107.
ClaxtonD FPlunkettWJrAndreeffMDesserothA BRetinoids and cancer therapy. Journal of the National Cancer Institute1921; 84: 1306–1307.
108.
MoonR CMcCormickD KMehtaR GInhibition of carcinogens by retinoids. Cancer Research1983;43, 5 (suppl): 2469s–2475s.
109.
ShklarGSchwartzJ. Oral cancer inhibition by micronutrients. The experimental basis for clinical trials. Oral Oncology European Journal of Cancer Part 131993;29B: 9–16.
110.
ShklarGSchwarzJGrauDTricklerD PWallaceK DInhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surgery1980;50: 45–52.
111.
ShklarGMarefatPKornhauserATricklerD PWallaceK DRetinoid inhibition of lingual carcinogenesis. Oral Surgery1980;49: 325–332.
112.
Burge-BottenbleyAShklarG. Retardation of experimental oral cancer development by retinyl acetate. Nutrition and Cancer1983;5: 121–129.
113.
SchwartzJSudaDLightG. Beta carotene is associated with the regression of hamster buccal pouch carcinoma and the induction of tumor necrosis factor in macrophages. Biochemical and Biophysical Research Communications1986;136: 1130–1135.
114.
SudaDSchwartzJShklarG. Inhibition of experimental oral carcinogenesis by topical beta carotene. Carcinogenesis1986;7: 711–715.
115.
SchwartzJ LFlynnEShklarG. The effect of carotenoids on the anti-tumour immune response in vivo and in vitro with hamsters and mouse immune effectors. Annals of the New York Academy of Sciences1990;587: 92–109.
116.
SchwartzJ LFlynnEShklarG. The effect of carotenoids on the antitumor immune response in vivo and in vitro with hamster and mouse immune effectors. Annals of the New-York Academy of Science1990;587: 92–109.
117.
GilmoreWGiuntaJ LThe effect of 13-cis-retinoic acid on hamster buccal pouch carcinogenesis. Oral Surgery1981;51: 256–265.
118.
SlagaT JFischerS MNelsonKGleasonG LStudies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proceedings of the National Academy of Science of the USA1980;77: 3659–3663.
119.
SpornM LNewtonD LRetinoids and chemoprevention of cancer. In: ZedeckM SLipkinM, eds. Inhibition of tumour induction and development. New York: Plenum Press, 1981;71–100.
120.
ShahJ PStrongE WDecosseJ JItriL MSellersP. Effect of retinoids on oral leukoplakia. Amercian Journal of Surgery1983;146: 466–470.
121.
HongW KItriLEndicottM JThe effectiveness of 13-cis-retinoic acid in the treatment of premalignant lesions in oral cavity. In: Proceedings of the American Society of Clinical Oncology, Chicago1985;4: 985 (abstract).
122.
TomaSMangianteP EMargarinoGNicoloGPalumboR. Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia. Oral Oncology European Journal of Cancer Part B1992;28B: 121–123.
123.
StichH FHornbyA PMathewBSankaranarayananRNairM KResponse of oral leukoplakias to the administration of vitamin A. Cancer Letters1988;40: 93–101.
124.
StichH FBrunnemannK DMathewBChemopreventive trials with vitamin A and beta-carotene: Some unresolved issues. Preventative Medicine1989;18: 732–739.
125.
StichH FMathewBSankaranarayananFNairM KRemission of oral precancerous lesions of tobacco/areca nut chewers following administration of beta-carotene or vitamin A and maintenance of the protective effect. Cancer Detection and Prevention1991;15: 93–98.
126.
StichH FMathewBSankaranarayananRNairM KRemission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of β-carotene or vitamin A. American Journal of Clinical Nutrition1991;53: 298S–304S.
127.
StichHRosinM PHornbyA PMathewBSankaranarayananRNairM KRemission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. International Journal of Cancer1988;42: 195–199.
128.
ChiesaFTradatiNMarazzaMRossiNPrevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Oral Oncology European Journal of Cancer1992;28B: 97–102.
129.
TradatiNChiesaFRossiNSuccessful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Letters1994;76: 109–111.
130.
MalakerKAndersonB JBeecroftW AHudsonD IManagement of oral mucosal dysplasia with beta carotene and retinoic acid; a pilot cross-over study. Cancer Detection and Prevention1991;15: 335–340.
131.
GarewalHSMeyskensF LKillenDResponse of oral leukoplakia to beta-carotene. Journal of Clinical Oncology1990;8: 1715–1720.
132.
GarewalH. Chemoprevention of oral cancer: Beta carotene and vitamin E in leukoplakia. European Journal of Cancer Prevention1994;3: 101–107.
133.
GarewalH SPotential role of β-carotene in prevention of oral cancer. American Journal of Clinical Nutrition1991;53: 294s–297s.
134.
GarewalH SPotential role of beta-carotene and antioxidant vitamins in the prevention of oral cancer. Annals of the New-York Academy of Science1992;669: 260–268.
135.
GarewalH SPitcockJFriedmanSBeta-carotene in oral leukoplakia. Proceedings of the American Society of Clinical Oncology (28th meeting) 1992;Vol 11: 141.
136.
GarewalH SMeyskensF. Retinoids and carotenoids in the prevention of oral cancer: A critical appraisal. Cancer Epidemiology Biomarkers and Prevention1992;1: 155–159.
137.
TomaSBensoSAlbaneseETreatment of oral leukoplakia with beta-carotene. Oncology1992;49: 77–81.
138.
LippmanS MBatsakisJ GThothB BComparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. New England Journal of Medicine1993;328: 15–20.
139.
HongW KLippmanS MItriL MPrevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New England Journal of Medicine1990;323: 795–801.
140.
Anonymous. Beta-carotene didn't prevent cancer: What's up doc?Journal of the National Cancer Institute1990;82: 899–900.
141.
KaugarsGBrandtRCarcaise-EdinboroPStraussRKilpatrickJ. Beta-carotene supplementation in the treatment of oral lesions. Oral Surgery, Oral Medicine, Oral Pathology1990;70: 607–608.
142.
KaugarsGESilvermanSLovasJGLA clinical trial of antioxidant supplements in the treatment of oral leukoplakia. Oral Surgery1994;78: 462–468.
143.
BrandtRKaugarsGSilvermanSRegression of oral lesions with the use of antioxidant vitamins and beta-carotene supplements. Pennington symposium ‘Vitamins and cancer prevention’. Louisiana State University Press, Baton Rouge, Louisiana, 1991.
144.
StichH FAndersF. The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. Mutation Research1989;214: 47–61.
145.
BollaMLefurRTon VanJPrevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. European Journal of Cancer1994;30A: 767–772.
146.
De VriesNVan ZandwijkNPastorinoU. The Euroscan Study. British Journal of Cancer1991;64: 985–989.
147.
De VriesNVan ZandwijkNPastorinoU. Chemoprevention in the management of oral cancer: Euroscan and other studies. Oral Oncology European Journal of Cancer1992;28B: 153–157.
148.
De VriesNPastorinoUVan ZandwijkN. Chemoprevention of second primary tumours in head and neck cancer in Europe: Euroscan. Oral Oncology European Journal of Cancer1994;30B: 367–368.
149.
BlockG. Vitamin C status and cancer. Epidemiologic evidence of reduced risk. Annals of the New York Academy of Science1992;669: 280–292.
150.
OdukoyaOHawachFShklarG. Retardation of experimental oral cancer by topical vitamin E. Nutrition and Cancer1984;6: 98–104.
151.
TricklerDShklarG. Prevention by vitamin E of experimental oral carcinogenesis. Journal of the National Cancer Institute1987;78: 165–169.
152.
ShklarG. Oral mucosal carcinogenesis in hamsters: Inhibition by vitamin E. Journal of the National Cancer Institute1982;68: 791–797.
153.
ShklarGSchwartzJTricklerDReidS. Regression of experimental cancer by oral administration of combined alpha-tocopherol and beta-carotene. Nutrition and Cancer1989;12: 321–325.
154.
BaroneJTaioliEHebertJ RWynderE LVitamin supplement use and risk for oral and esophageal cancer. Nutrition and Cancer1992;18: 31–41.
155.
BennerS ESinnR JLippmanS MRegression of oral leukoplakia with Â-tocopherol: A community clinical oncology program chemoprevention study. Journal of the National Cancer Institute1993;85: 44–47.
156.
ZaridzeDEvstifeevaTBoyleP. Chemoprevention of oral leukoplakia and chronic oesophagitis in an area of high incidence of oral and esophageal cancer. Annals of Epidemiology1993;3: 225–234.
157.
SmigelK. Vitamin E moves on stage in cancer prevention studies. Journal of the National Cancer Institute1992;84: 996–997.
158.
GridleyGMcLaughlinJ KBlockGBlotW JGluchMFraumeniJ FJr.Vitamin supplement use and reduced risk ot oral and pharyngeal cancer. American Journal of Epidemiology1992;135: 1083–1092.
159.
BennerS EWargovichM JLippmanS MReduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia. Cancer Epidemiology Biomarkers and Prevention1994;3: 73–76.
160.
SchantzSPHongWKBooneCWKelloffGJ, eds. Chemoprevention of premalignant lesions of the upper acrodigestive tract. Journal of Cellular Biochemistry1993;Supplement 17F.